[1]
R. Grabysa and A. Chmielewska, “Cardiovascular complications during the treatment of castration-resistant prostate cancer with the use of modern antiandrogens: abiraterone acetate and enzalutamide”, OncoReview, vol. 11, no. 3(43), pp. 61-67, Sep. 2021.